NCT06850103 2026-03-25
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
Clinical Trials
16 trialsNCT07448142 2026-03-04
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT07229846 2026-01-08
A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
Harbin Medical University
Phase 2 Not yet recruiting
NCT06475352 2025-01-27
FUDOSE
UNICANCER
Phase 2 Recruiting
NCT01531595 2024-12-12
AXOAXI
Helsinki University Central Hospital
Phase 2 Active not recruiting
NCT04659382 2023-08-18
SIRTCI
Federation Francophone de Cancerologie Digestive
Phase 2 Unknown
NCT05193292 2022-01-14
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT00551213 2018-08-24
A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT03511170 2018-05-01
XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
Phase 2 Unknown
NCT03511183 2018-05-01
XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
Phase 2 Unknown
NCT02870153 2016-08-19
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Phase 2 Unknown
NCT02075086 2015-03-17
ANGIOSWITCH
Grupo Hospital de Madrid
Phase 2 Unknown
NCT00378066 2013-01-23
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
Asan Medical Center
Phase 2 Completed
NCT00677144 2012-10-05
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Hallym University Medical Center
Phase 2 Completed
NCT00220116 2010-01-06
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
Royal Marsden NHS Foundation Trust
Phase 2 Completed
NCT00997685 2009-10-19
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
Guangdong Provincial People's Hospital
Phase 2 Unknown